BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This biomimetic proteoliposome material features bovine serum albumin functionalized and liver-targeted ligand co-modified liposomes. The macromolecular architecture incorporates a precise molecular fraction of a custom synthesized liver-targeting lipid conjugate (such as a galactosylated or glycyrrhetinic acid-linked anchor) within its high-purity phospholipid-cholesterol bilayer shell, whose exterior polar interface is enveloped by a covalently linked or electrostatically bound outer layer of the water-soluble transport protein bovine serum albumin (BSA). This precise configuration presents a balanced target-mimetic interface and alters overall membrane bending elasticity, utilizing the protein matrix to establish a stable biomimetic template that completely prevents macromolecular self-aggregation or rapid phase separation across variable laboratory testing setups while leaving the internal aqueous core completely empty.
Source
Custom synthesis
Functional Group
Bovine serum albumin (BSA)
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.